Abstract
The aim of this report is to provide a range of information-from detailed
market analyses through industry trends-to quantify, qualify and compare the
herbal supplement, prescription drug (including generics) and (where
applicable) over-the-counter (OTC) drug markets for a variety of diseases with
large patient bases.
This report offers a unique perspective on diseases for which herbal
supplements as well as prescription drugs and, in some cases, OTC treatments
are available. The purpose of the report is to compare trends in these
treatment options and provide market assessments and forecasts for each. The
information and analysis presented in this report are important assets in
decision-making for managers involved in business development, marketing,
market research, product development, mergers and acquisitions, licensing,
business management, investment banking and deal creation, and to consultants
to the healthcare, herbal supplement, prescription pharmaceutical and OTC
treatment industry. The study provides a comprehensive analysis of the current
markets for herbal supplements, prescription drugs and (where applicable) OTC
products for the treatment of benign prostatic hyperplasia, cognitive
disorders, depression, erectile dysfunction, gastrointestinal disorders
(heartburn and nausea), hypercholesterolemia, hypertension, insomnia and
menopausal symptoms.
SCOPE OF STUDY
This report contains:
- The major current and emerging markets for herbal supplements,
prescription drugs and (where applicable) OTC treatments
- An overview section that provides a discussion of the emergence of the
herbal supplements market, U.S. and overseas regulations and guidelines
relating to this market, sources of raw materials and concerns about
sustainability of herbal harvesting practices
- A global forecast for the herbal supplement and OTC market, with a
five-year forecast date to 2011
- The latest company profiles for the top companies in the market
- A detailed patent analysis.
METHODOLOGY
The base year for this study is 2006. Figures are based on revenue numbers at
the manufacturers' level and are projected at 2006 dollar value; that is,
inflation is not computed into the projection figures.
This study was prepared with data and trends derived from herbal products
specialists and organizations, pharmaceutical product managers, marketing
strategists, research executives and others at leading herbal and
pharmaceutical companies that have products used in the treatment of diseases
covered in this report or which have products in development for these markets.
INFORMATION SOURCES
The information and analyses presented in this report are based on an
extensive survey of the herbal supplement/nutritional products and
pharmaceutical industries as well as a detailed examination of published
literature and reports obtained from regulatory authorities, medical research
institutions, pharmaceutical trade associations and national and world health
organizations. Key information from business literature was used to obtain
expert opinions on commercial potential and market sizes from industry
professionals.
| 
View Cart
